BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17449900)

  • 1. Interventions to reduce weight gain in schizophrenia.
    Faulkner G; Cohn T; Remington G
    Schizophr Bull; 2007 May; 33(3):654-6. PubMed ID: 17449900
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of lifestyle interventions and weight management in schizophrenia.
    Bushe C; Haddad P; Peveler R; Pendlebury J
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):28-35. PubMed ID: 16280335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of weight gain in patients with schizophrenia.
    Aquila R
    J Clin Psychiatry; 2002; 63 Suppl 4():33-6. PubMed ID: 11913674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
    Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
    J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?
    Housel AK; Waterbury N; Argo TR
    Issues Ment Health Nurs; 2009 Dec; 30(12):803-5. PubMed ID: 19916816
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
    Himmerich H; Schuld A; Pollmächer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction. Weight gain with psychotropics: size does matter.
    Masand PS
    J Clin Psychiatry; 1999; 60 Suppl 21():3-4. PubMed ID: 10548134
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.
    Hasnain M; Fredrickson SK; Vieweg WV
    J Psychopharmacol; 2011 Jun; 25(6):715-21. PubMed ID: 21169390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.
    Das C; Mendez G; Jagasia S; Labbate LA
    Ann Clin Psychiatry; 2012 Aug; 24(3):225-39. PubMed ID: 22860242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antipsychotic-induced weight gain--pharmacogenetic studies].
    Olajossy-Hilkesberger L; Godlewska B; Marmurowska-Michałowskal H; Olajossy M; Landowski J
    Psychiatr Pol; 2006; 40(5):1009-20. PubMed ID: 17217242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of antipsychotic-induced weight gain.
    McIntyre RS; Mancini DA; Basile VS
    J Clin Psychiatry; 2001; 62 Suppl 23():23-9. PubMed ID: 11603882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing treatment guidelines.
    Miller AL
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):15-6. PubMed ID: 21459734
    [No Abstract]   [Full Text] [Related]  

  • 18. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative descriptive study exploring schizophrenia and the everyday effect of medication-induced weight gain.
    Vandyk AD; Baker C
    Int J Ment Health Nurs; 2012 Aug; 21(4):349-57. PubMed ID: 22404848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the central control of weight regulation and the effect of antipsychotic medication.
    Tighe S; Dinan T
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):36-46. PubMed ID: 16280336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.